FDAnews
www.fdanews.com/articles/100670-abbott-confirms-fda-advisory-panel-to-review-xience-v-drug-eluting-stent-on-november-29

Abbott Confirms FDA Advisory Panel to Review Xience V Drug Eluting Stent on November 29

November 5, 2007

Abbott announced that the U.S. Food and Drug Administration (FDA) has confirmed a Circulatory Systems Devices Advisory Panel meeting on November 29, 2007, to review the company’s Premarket Approval (PMA) submission for the XIENCE V Everolimus Eluting Coronary Stent System.
Abbott